All Posts

FemPulse Receives FDA Clearance to Begin Pivotal Trial for Women’s Overactive Bladder Device

FemPulse has received FDA Investigational Device Exemption (IDE) approval to begin its EVANESCE II pivotal clinical trial for its wearable bioelectronic device targeting overactive bladder (OAB) in women. The device, called the FemPulse Ring, is designed as a vaginally-inserted, removable treatment option. “We want to thank everyone at FDA for their thorough review and clear dedication to patient safety. This is an…

Ro Partners with Lilly to Offer Direct Access to Zepbound Weight Loss Treatment

Healthcare company Ro has announced a collaboration with Eli Lilly and Company to provide patients with streamlined access to Zepbound (tirzepatide) single-dose vials through LillyDirect’s self-pay pharmacy channel. The integration will allow clinically eligible Ro patients to receive the FDA-approved obesity treatment directly through Ro’s platform. Eli Lilly launched LillyDirect earlier this year, marking the first time a major pharmaceutical company has…

Lushi Launches Patient-Centric Fertility Care Services with $5M in Seed Funding

Lushi, a new startup aimed at transforming the fertility care experience, recently launched with $5 million in funding. The company, founded by former PR executive Jessica Schaefer, introduces its platform with a suite of services designed to make fertility preservation more accessible and less intimidating for women. Schaefer’s personal experience with egg freezing inspired the creation of Lushi. “The process was incredibly…

Asan Cup Launches Period Tracking App with Environmental Impact Features

Menstrual cup company Asan Cup has released a new free period tracking app that allows users to monitor both their cycles and the environmental impact of their period product choices. The app, backed by Innovate UK’s Unlocking Potential Award and developed in collaboration with Old St Labs, enables users to track cycle phases, mood, flow, and symptoms while providing real-time data about…

Redesign Health Secures $175M Fund to Build Healthcare Ventures

Redesign Health, a healthcare venture builder, has announced the closing of a $175 million fund to support healthcare company creation. The new fund includes investment from Declaration Partners, Euclidean Capital, and True North Advisors. “Healthcare founders today benefit from unprecedented tailwinds. AI, aligned payment models, patient demand for better care, and unsustainable cost pressures set the stage for generational value creation and…

Mental Health Platform for Asian Americans Anise Health Raises $3M Seed Round

Anise Health, a digital mental health platform focused on culturally-responsive care for Asian Americans, has announced a $3M seed funding round led by Kicker Ventures. The round saw participation from Authentic Heart, Change Paradox Ventures, Progression Fund, How Women Invest, Celtic House Asia Partners, Nextblue, Gold House Ventures, and several angel investors, along with a grant from the National Institute of Mental…

What’s New in Femtech This Week? (Dec 12, 2024)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Nua Surgical raises €6.5M Series A for C-section retractor innovation. ModifyHealth secures $13.5M Series C to expand food-as-a-medicine platform. Women’s health platform Unfabled launches supplement range at UK’s Boots…

The White House Conference on Women’s Health Research: What’s Next?

On my flight to DC yesterday morning for the first-ever White House Conference on Women’s Health Research, I looked down at my shirt: “Tout est possible.” Everything is possible. Hours later, I’d hear President Biden echo a similar sentiment in the East Room of the White House, talking about America and possibilities. Sometimes coincidences feel meaningful, especially on days that highlight both…